In a May 7, 2024 press release, Seragon Biosciences announced that its aging intervention drug candidate, SRN-901, achieved one of the largest extensions of
RESTORIN activates key longevity pathways like DNA repair, mTOR inhibition, and cognitive support, offering a scientifically-backed approach to extending healthspan.
In the quest for improved health and longevity, scientists have been digging deeper into our cellular makeup, uncovering the building blocks that could be